Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Cancer Research

• Publication date

  1998-12-01

• Fields of study

  Medicine

• Identifiers
  PMID 9850075
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microautoradiographic quantitation of vascular endothelial growth factor mRNA levels in human prostate specimens containing normal and neoplastic epithelium.

  1998cited by this paper
• Expression of vascular endothelial growth factor and its receptors in the rat ventral prostate and Dunning R3327 PAP adenocarcinoma before and after castration

  1998cited by this paper
• Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies.

  1997cited by this paper
• Transrectal ultrasound-guided biopsy causes hematogenous dissemination of prostate cells as determined by RT-PCR.

  1997cited by this paper
• Radiation-based approaches to the management of T3 prostate cancer.

  1997cited by this paper
• Brachytherapy for clinically localized prostate cancer: results at 7- and 8-year follow-up.

  1997cited by this paper
• Adjuvant intraoperative photodynamic therapy in experimental colorectal cancer using a new photosensitizer

  1997cited by this paper
• Cryosurgical ablation of prostate cancer: patterns of cancer recurrence.

  1997cited by this paper
• Intraperitoneal Photodynamic Therapy: Comparison of Red and Green Light Distribution and Toxicity

  1997cited by this paper
• Photodynamic therapy inhibits cell adhesion without altering integrin expression.

  1997cited by this paper
• Prostate cancer screening and management.

  1997cited by this paper
• Thermal Ablation of Canine Prostate Using Interstitial Temperature Self-Regulating Seeds: New Treatment for Prostate Cancer

  1997cited by this paper
• Interstitial photodynamic therapy in the canine prostate with disulfonated aluminum phthalocyanine and 5‐aminolevulinic acid‐induced protoporphyrin IX

  1997cited by this paper
• Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer.

  1997cited by this paper
• Models for cancer skeletal metastasis: a reappraisal of Batson's plexus.

  1997cited by this paper
• Proliferative response of human prostate tumour xenografts to surgical trauma and the transurethral resection of the prostate controversy.

  1996cited by this paper
• Intraperitoneal photodynamic therapy of human epithelial ovarian carcinomatosis in a xenograft murine model.

  1996cited by this paper
• Analysis of tumor spillage during radical prostatectomy using RT-PCR of prostate specific antigen.

  1996cited by this paper
• Photodynamic Therapy of Brain Tumors

  1996cited by this paper
• Clinical and preclinical photodynamic therapy

  1995cited by this paper
• In situ COMPARISON OF 665 nm and 633 nm WAVELENGTH LIGHT PENETRATION IN THE HUMAN PROSTATE GLAND

  1995cited by this paper
• Effect of N‐acetylcysteïne on photofrin‐induced skin photosensitivity in patients

  1995cited by this paper
• Adjuvant intraoperative photodynamic therapy diminishes the rate of local recurrence in a rat mammary tumour model.

  1995cited by this paper
• Molecular genetics of prostate cancer.

  1995cited by this paper
• Long-term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladder.

  1995cited by this paper
• Photodynamic therapy of brain tumors.

  1995cited by this paper
• Photodynamic therapy for recurrent supratentorial gliomas.

  1995cited by this paper
• Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy.

  1995cited by this paper
• The effect of transurethral light on the canine prostate after sensitization with the photosensitizer tin (II) etiopurpurin dichloride: a pilot study.

  1994cited by this paper
• Photodynamic therapy in dermatology with porfimer sodium and benzoporphyrin derivative: an update.

  1994cited by this paper
• Photodynamic therapy as an adjuvant intraoperative treatment of recurrent head and neck carcinomas

  1994cited by this paper
• Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays.

  1994cited by this paper
• Adjuvant intraoperative photodynamic therapy for colorectal carcinoma: a clinical study.

  1994cited by this paper
• Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer.

  1994cited by this paper
• Intraperitoneal photodynamic therapy in the rat: Comparison of toxicity profiles for photofrin and mTHPC

  1994cited by this paper
• PHOTOPHYSICAL AND PHOTOSENSITIZING PROPERTIES OF BENZOPORPHYRIN DERIVATIVE MONOACID RING A (BPD‐MA) *

  1994cited by this paper
• ACTIVATION OF BENZOPORPHYRIN DERIVATIVE IN THE CIRCULATION OF MICE WITHOUT SKIN PHOTOSENSITIVITY

  1994cited by this paper
• An experimental model simulating local recurrence and pelvic lymph node metastasis following orthotopic induction of prostate cancer

  1994cited by this paper
• Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years.

  1994cited by this paper
• Modulation of colonic cancer cell adhesiveness by haematoporphyrin derivative photodynamic therapy.

  1994cited by this paper
• OPTIMIZATION OF MULTIFIBER LIGHT DELIVERY FOR THE PHOTODYNAMIC THERAPY OF LOCALIZED PROSTATE CANCER

  1993cited by this paper
• OPTICAL PROPERTIES OF EXPERIMENTAL PROSTATE TUMORS in vivo

  1993cited by this paper
• Measurement of PDT-induced hypoxia in Dunning prostate tumors by iodine-123-iodoazomycin arabinoside.

  1993cited by this paper
• The role of intraabdominal pressure in venous blood drainage from the prostate into the vertebral vein system.

  1993cited by this paper
• HOW DOES PHOTODYNAMIC THERAPY WORK?

  1992cited by this paper
• The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion.

  1992cited by this paper
• CHANGES IN TUMOR INTERSTITIAL PRESSURE INDUCED BY PHOTODYNAMIC THERAPY

  1991cited by this paper
• Intraoperative phototherapy (PDT) and surgical resection in a mouse neuroblastoma model

  1990cited by this paper
• The significance of the nature of the photosensitizer for photodynamic therapy: quantitative and biological studies in the colon.

  1990cited by this paper
• Photodynamic therapy of localised prostatic cancer.

  1990cited by this paper
• Photodynamic therapy for localised prostatic cancer: light penetration in the human prostate gland.

  1990cited by this paper
• Patterns of tumor metastasis: organ selectivity in the spread of cancer cells.

  1988cited by this paper
• Intraoperative photodynamic therapy for retroperitoneal sarcomas

  1988cited by this paper
• Photodynamic Therapy

  1988cited by this paper
• Preliminary studies on a more effective phototoxic agent than hematoporphyrin.

  1987cited by this paper
• The effect of localized porphyrin photodynamic therapy on the induction of tumour metastasis.

  1987cited by this paper
• The dissemination of cancer by transurethral resection of locally advanced prostate cancer.

  1983cited by this paper
• The Science of Photomedicine

  1982cited by this paper
• The characterization of a newly identified, highly metastatic variety of Dunning R 3327 rat prostatic adenocarcinoma system: the MAT LyLu tumor.

  1981cited by this paper
• Cancer cells in the circulating blood during operative management of genitourinary tumors.

  1961cited by this paper

• Post-Operational Photodynamic Therapy of the Tumor Bed: Comparative Analysis for Cold Knife and Laser Scalpel Resection

  2024cites this paper
• A Dual Function Antibody Conjugate Enabled Photoimmunotherapy Complements Fluorescence and Photoacoustic Imaging of Head and Neck Cancer Spheroids

  2023cites this paper
• Dual-Function Antibody Conjugate-Enabled Photoimmunotherapy Complements Fluorescence and Photoacoustic Imaging of Head and Neck Cancer Spheroids

  2023cites this paper
• PSMA1-mediated ultrasmall gold nanoparticles facilitate tumor targeting and MR/CT/NIRF multimodal detection of early-stage prostate cancer.

  2022cites this paper
• EGFR-targeted multi-modal molecular imaging and treatment in a heterocellular model of head and neck cancer

  2022cites this paper
• Spotlight on Photoactivatable Liposomes beyond Drug Delivery: An Enabler of Multitargeting of Molecular Pathways.

  2022cites this paper
• Minimally invasive magnetic resonance image-guided prostate interventions

  2021cites this paper
• Dual Function Antibody Conjugates for Multimodal Imaging and Photoimmunotherapy of Cancer Cells

  2021cites this paper
• DNA Hypermethylation Involves in the Down-Regulation of Chloride Intracellular Channel 4 (CLIC4) Induced by Photodynamic Therapy

  2021cites this paper
• Juglone-loaded metal-organic frameworks for H2O2 self-modulating enhancing chemodynamic therapy against prostate cancer

  2021cites this paper
• Gauging the Impact of Cancer Treatment Modalities on Circulating Tumor Cells (CTCs)

  2020cites this paper
• Microtubule disruption reduces metastasis more effectively than primary tumor growth

  2020cites this paper
• The Role of Photoactivated and Non-Photoactivated Verteporfin on Tumor

  2020cites this paper
• Role of Ultrasound and Photoacoustic Imaging in Photodynamic Therapy for Cancer

  2020cites this paper
• Role of Photoactive Phytocompounds in Photodynamic Therapy of Cancer

  2020cites this paper
• Low-dose photodynamic therapy-induced increase in the metastatic potential of pancreatic tumor cells and its blockade by simvastatin.

  2020cites this paper
• Tumor cell death in orthotopic breast cancer model by NanoALA: a novel perspective on photodynamic therapy in oncology.

  2020cites this paper
• PSA targeted dual-modality manganese oxide-mesoporous silica nanoparticles for prostate cancer imaging.

  2019cites this paper
• Recent progress in H2S activated diagnosis and treatment agents

  2019cites this paper
• Cell Death Pathways Associated with Photodynamic Therapy: An Update

  2018cites this paper
• Prostate-Specific Membrane Antigen Targeted Gold Nanoparticles for Theranostics of Prostate Cancer.

  2018cites this paper
• 21 Spectroscopic imaging in prostate PDT

  2017cites this paper
• Efficacy of photochemical internalisation using disulfonated chlorin and porphyrin photosensitisers: An in vitro study in 2D and 3D prostate cancer models

  2017cites this paper
• On the in vivo photochemical rate parameters for PDT reactive oxygen species modeling

  2017cites this paper
• Photodynamic Therapy: Past, Present and Future.

  2017cites this paper
• Reversal of the Migratory and Invasive Phenotype of Ras‐Transfected Mammary Cells by Photodynamic Therapy Treatment

  2017cites this paper
• Theranostic Agents for Photodynamic Therapy of Prostate Cancer by Targeting Prostate-Specific Membrane Antigen

  2016cites this paper
• Prostate Cancer Diagnosis Based on the Segmentation and Analysis of NIR Images Obtained Using Two PSMA-1 Based PDT Conjugates PSMA-1-Pc413 and PSMA-1-IR700

  2016cites this paper
• Evaluation of nanoencapsulated verteporfin's cytotoxicity using a microfluidic system.

  2016cites this paper
• Light-based therapies in prostate cancer treatment

  2016influential citation
• 23 – Advancing photodynamic therapy with biochemically tuned liposomal nanotechnologies

  2015cites this paper
• Isolation and characterization of PDT-resistant cancer cells

  2015cites this paper
• Animal models for photodynamic therapy (PDT)

  2015cites this paper
• The role of cytoskeleton and adhesion proteins in the resistance to photodynamic therapy. Possible therapeutic interventions

  2015cites this paper
• Isolation and Initial Characterization of Resistant Cells to Photodynamic Therapy

  2015cites this paper
• Mechanisms of Resistance to Photodynamic Therapy: An Update

  2015cites this paper
• ALA- or Ce6-PDT induced phenotypic change and suppressed migration in surviving cancer cells

  2015cites this paper
• Optimization of proteolytically induced photosensitizers for fluorescence imaging and Photodynamic Therapy

  2014cites this paper
• Inactivation of multidrug resistant (MDR)- and extensively drug resistant (XDR)-Mycobacterium tuberculosis by photodynamic therapy.

  2013cites this paper
• Pulmonary metastases of the A549-derived lung adenocarcinoma tumors growing in nude mice. A multiple case study.

  2013cites this paper
• Chloride intracellular channel 4 involves in the reduced invasiveness of cancer cells treated by photodynamic therapy

  2013cites this paper
• Photodynamic therapy induced cell death of hormone insensitive prostate cancer PC-3 cells with autophagic characteristics.

  2013cites this paper
• Selective Photodetection and Photodynamic Therapy for Prostate Cancer through Targeting of Proteolytic Activity

  2012cites this paper
• Circulating tumor cells

  2012cites this paper
• Circulating tumor cells as emerging tumor biomarkers in lung cancer.

  2012cites this paper
• Perspectives on the Role of Photodynamic Therapy in the Treatment of Pancreatic Cancer

  2012cites this paper
• Photodynamic therapy in the treatment of prostate cancer

  2011cites this paper
• Approaches to improve photodynamic therapy of cancer.

  2011cites this paper
• Type 1 phototherapeutic agents, part I: preparation and cancer cell viability studies of novel photolabile sulfenamides.

  2011cites this paper
• Mechanisms of resistance to photodynamic therapy.

  2011cites this paper
• The effects of photodynamic therapy with Photodithazine on HPV 16 E6/E7 associated cervical cancer model

  2011cites this paper
• Combined surgery and photodynamic therapy of cancer

  2010cites this paper
• Enhancement of anti-tumor immunity by photodynamic therapy

  2010cites this paper
• Composés et compositions pour une utilisation en photothérapie et dans le traitement d'une maladie néovasculaire oculaire et de cancers

  2010cites this paper
• Title Treatment of Canine Osseous Tumors with Photodynamic Therapy : A Pilot Study Permalink

  2009cites this paper
• Image-Guided Photodynamic Cancer Therapy

  2009cites this paper
• Preliminary study of verteporfin photodynamic therapy in a canine prostate model

  2009cites this paper
• Treatment of Canine Osseous Tumors with Photodynamic Therapy: A Pilot Study

  2009cites this paper
• Photodynamic Therapy: A Systems Biology Approach

  2009cites this paper
• Effect of 5-ALA-PDT on VEGF and PCNA expression in human NPC-bearing nude mice.

  2009cites this paper
• ALA‐PDT results in phenotypic changes and decreased cellular invasion in surviving cancer cells

  2009cites this paper
• Decreased metastatic phenotype in cells resistant to aminolevulinic acid-photodynamic therapy.

  2008cites this paper
• Noninvasive fluorescence monitoring for functional assessment of murine glioma treatment

  2008cites this paper
• Enhancing Tumor Drug Delivery by Laser-Activated Vascular Barrier Disruption

  2008cites this paper
• Photodynamic Therapy of the Canine Prostate: Intra-arterial Drug Delivery

  2008cites this paper
• In vivo Optical Molecular Imaging of Vascular Endothelial Growth Factor for Monitoring Cancer Treatment

  2008cites this paper
• Molecular imaging of photodynamic therapy efficacy

  2007cites this paper
• Preclinical models of regional lymph node tumor metastasis.

  2007cites this paper
• CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells

  2007cites this paper
• The history of PDT in Norway Part II. Recent advances in general PDT and ALA-PDT.

  2007cites this paper
• The effect of Tookad-mediated photodynamic ablation of the prostate gland on adjacent tissues—in vivo study in a canine model

  2007cites this paper
• In vivo, on-line monitoring of molecular response to photodynamic therapy: molecular imaging of vascular endothelial growth factor

  2007cites this paper
• Tumor cell lines resistant to ALA-mediated photodynamic therapy and possible tools to target surviving cells.

  2006cites this paper
• Evaluation of Tookad-mediated photodynamic effect on peripheral nerve in a canine model

  2006cites this paper
• A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer.

  2006cites this paper
• Tumor Vascular Permeabilization by Vascular-Targeting Photosensitization: Effects, Mechanism, and Therapeutic Implications

  2006cites this paper
• Protoporphyrin IX Level Correlates with Number of Mitochondria, But Increase in Production Correlates with Tumor Cell Size

  2006cites this paper
• Analysis of cell line variation in biochemical production of protoporphyrin IX

  2006cites this paper
• In Vivo Imaging of VEGF Expression for Monitoring Molecular Response to Cancer Therapy

  2006cites this paper
• Pretreatment photosensitizer dosimetry reduces variation in tumor response.

  2006cites this paper
• Photosensitizer dosimetry controlled PDT treatment planning reduces inter-individual variability in response to PDT

  2006cites this paper
• Prostate PDT dosimetry.

  2006influential citation
• Nuclear estrogen receptor targeted photodynamic therapy: Selective uptake and killing of MCF‐7 breast cancer cells by a C17α‐alkynylestradiol‐porphyrin conjugate

  2006cites this paper
• Molecular imaging of photodynamic therapy

  2006cites this paper
• Review of photodynamic therapy.

  2006cites this paper
• Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model.

  2005cites this paper
• In vitro and in vivo activities of verteporfin-loaded nanoparticles.

  2005cites this paper
• Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy.

  2005cites this paper
• Optical Strategies for Studying Metastatic Mechanisms, Tumor Cell Detection and Treatment of Prostate Cancer

  2005cites this paper
• Role of Photodynamic Therapy for Bone Metastasis

  2005cites this paper
• Tookad-mediated photodynamic effects on the prostate and its adjacent tissues: in vivo study in canine models

  2005cites this paper
• Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death.

  2005cites this paper
• The influence of photodynamic therapy on the immune response.

  2005cites this paper
• Results 28 months following transpupillary thermotherapy for classic and occult choroidal neovascularization in patients with age-related macular degeneration.

  2005cites this paper
• Effects of Photodynamic Therapy on Peripheral Nerve: In Situ Compound-Action Potentials Study in a Canine Model

  2005cites this paper
• Antiangiogenic photodynamic therapy (PDT) using Visudyne causes effective suppression of tumor growth.

  2004cites this paper
• Role of cell type and animal species in tumor metastasis

  2004cites this paper
• Effective Photoimmunotherapy of Murine Colon Carcinoma Induced by the Combination of Photodynamic Therapy and Dendritic Cells

  2004cites this paper
• Effects of Pd-bacteriopheophorbide (TOOKAD)-Mediated Photodynamic Therapy on Canine Prostate Pretreated with Ionizing Radiation

  2004cites this paper
• Effects of Photodynamic Therapy on Tumor Stroma

  2004cites this paper